Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-26 @ 11:12 PM
Ignite Modification Date: 2025-12-26 @ 11:12 PM
NCT ID: NCT04105712
Eligibility Criteria: Inclusion Criteria: * Age 25 to 40 * Access to internet, private computer and smart phone * Overweight (self-report BMI above 25.0) * Moderately or Highly motivated to eat a healthier diet * Mild, moderate or severe levels of addictive like eating (2 or higher on the Yale Food Addiction Scale) * Fluent in english * Willing to follow dietary guidelines provided by study team and eat only provide food for 3 days. Willing to delay dietary change until instructed to do so Exclusion Criteria: * Use of nicotine in the past month, cannabis in the past month, or illicit drugs in the past 6 months * Weight fluctuation of 20+ pounds in the last 3 months * Attempted weight loss using a formal weight loss program (e.g. weight watchers) in the last month * Prior weight loss surgery (e.g. bariatric surgery) * Medications or medical conditions that may impact study results such as medications that impact appetite, heart rate, or reward functioning (e.g. taking synthroid or has diabetes) * Current major psychiatric diagnoses (e.g., bipolar, schizophrenia, substance use disorder, eating disorder) * A diagnosis of a restrictive eating disorder in the past 5 years (anorexia nervosa, bulimia nervosa, purging disorder) * Significant dietary restrictions (e.g. allergies, veganism) * currently pregnant, breastfeeding, trying to get pregnant, or within 6 months of giving birth
Healthy Volunteers: True
Sex: ALL
Minimum Age: 25 Years
Maximum Age: 40 Years
Study: NCT04105712
Study Brief:
Protocol Section: NCT04105712